Who should receive antiendotoxin monoclonal antibody therapy?
Hardin
T C
TC
DiPiro
J T
JT
D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D061067:Antibodies, Monoclonal, Humanized; D016527:Drug Costs; D016905:Gram-Negative Bacterial Infections / Q000188:drug therapy*; D006801:Humans; D007075:Immunoglobulin M; D010606:Pharmacy and Therapeutics Committee
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007075:Immunoglobulin M; C071470:edobacomab; C068069:nebacumab